|
|
|
Insider
Information: |
Fust Matthew K |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
355,244 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$8,187,672 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
355,244 |
|
|
Total
Value |
$8,187,672 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-17.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Jazz Pharmaceuticals Inc |
JAZZ |
EVP, Chief Financial O... |
2008-11-28 |
58,948 |
|
0 |
Premium* |
|
Onyx Pharmaceuticals Inc |
ONXX |
EVP & Chief Financial ... |
2013-10-01 |
0 |
2009-01-05 |
0 |
Premium* |
|
Ultragenyx Pharmaceutical Inc |
RARE |
|
2024-03-07 |
14,860 |
2014-01-30 |
0 |
Premium* |
|
Macrogenics Inc |
MGNX |
Director |
2019-02-06 |
500 |
|
0 |
Premium* |
|
Atara Biotherapeutics, Inc. |
ATRA |
|
2024-03-31 |
259,000 |
2015-05-15 |
0 |
Premium* |
|
Crinetics Pharmaceuticals, Inc. |
CRNX |
|
2024-06-07 |
21,936 |
2019-12-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
97 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ATRA |
Atara Biotherapeutics, In... |
Director |
|
2018-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,500 |
21,854 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
Director |
|
2018-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
11,750 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
Director |
|
2019-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
14,750 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
Director |
|
2019-06-27 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
25,854 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
Director |
|
2020-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
33,854 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
|
|
2021-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
11,000 |
44,854 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
Director |
|
2021-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,145 |
15,695 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
|
|
2022-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
20,500 |
52,000 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
Director |
|
2022-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
3,300 |
26,495 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
|
|
2023-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
57,000 |
109,000 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
Director |
|
2023-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,860 |
30,355 |
0 |
- |
|
CRNX |
Crinetics Pharmaceuticals... |
Director |
|
2023-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
18,536 |
0 |
- |
|
ATRA |
Atara Biotherapeutics, In... |
|
|
2024-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
259,000 |
0 |
- |
|
CRNX |
Crinetics Pharmaceuticals... |
|
|
2024-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,400 |
21,936 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, Chief Financial Officer |
|
2008-11-28 |
4 |
A |
$1.28 |
$485 |
D/D |
379 |
58,948 |
0 |
- |
|
CRNX |
Crinetics Pharmaceuticals... |
Director |
|
2019-12-16 |
4 |
OE |
$1.91 |
$6,685 |
D/D |
3,500 |
16,036 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP and CFO |
|
2008-05-30 |
4 |
A |
$6.50 |
$7,820 |
D/D |
1,203 |
58,569 |
0 |
- |
|
CRNX |
Crinetics Pharmaceuticals... |
Director |
|
2022-07-13 |
4 |
OE |
$1.45 |
$8,265 |
D/D |
5,700 |
18,236 |
0 |
- |
|
CRNX |
Crinetics Pharmaceuticals... |
Director |
|
2021-07-12 |
4 |
OE |
$1.91 |
$9,550 |
D/D |
5,000 |
17,536 |
0 |
- |
|
CRNX |
Crinetics Pharmaceuticals... |
Director |
|
2021-07-26 |
4 |
OE |
$1.91 |
$9,550 |
D/D |
5,000 |
17,536 |
0 |
- |
|
CRNX |
Crinetics Pharmaceuticals... |
Director |
|
2021-09-08 |
4 |
OE |
$1.91 |
$11,548 |
D/D |
6,046 |
18,582 |
0 |
- |
|
CRNX |
Crinetics Pharmaceuticals... |
Director |
|
2021-11-01 |
4 |
OE |
$1.91 |
$17,102 |
D/D |
8,954 |
21,490 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
SVP and CFO |
|
2007-11-30 |
4 |
A |
$13.18 |
$18,294 |
D/D |
1,388 |
51,085 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
Chief Financial Officer |
|
2012-03-02 |
4 |
AS |
$37.52 |
$22,212 |
D/D |
(592) |
48,237 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
Chief Financial Officer |
|
2011-04-01 |
4 |
AS |
$35.02 |
$28,016 |
D/D |
(800) |
45,801 |
0 |
- |
|
97 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|